Maeda Yumi, Mukai Tetsu, Kai Masanori, Fukutomi Yasuo, Nomaguchi Hiroko, Abe Chiyoji, Kobayashi Kazuo, Kitada Seigo, Maekura Ryoji, Yano Ikuya, Ishii Norihisa, Mori Toru, Makino Masahiko
Department of Microbiology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
FEMS Microbiol Lett. 2007 Jul;272(2):202-5. doi: 10.1111/j.1574-6968.2007.00754.x. Epub 2007 May 22.
As serodiagnosis is the easiest way of diagnosing a disease, the utility of Mycobacterium leprae-derived major membrane protein-II (MMP-II), one of the immuno-dominant antigens, in the serodiagnosis of leprosy was examined. The percent positivity by an enzyme-linked immunosorbent assay for anti-MMP-II antibody was 82.4% for multi-bacillary leprosy, and the specificity of the test was 90.1%. For pauci-bacillary leprosy where cell-mediated immunity predominates, 39.0% showed positive results. These percentage values were significantly higher than these values obtained for existing phenolic glycolipid-I based methods, suggesting that MMP-II antibody detection would facilitate the diagnosis of leprosy.
由于血清学诊断是疾病诊断的最简便方法,因此对麻风分枝杆菌来源的主要膜蛋白-II(MMP-II)(免疫显性抗原之一)在麻风病血清学诊断中的效用进行了研究。酶联免疫吸附测定抗MMP-II抗体的阳性率在多菌型麻风病中为82.4%,该检测的特异性为90.1%。对于以细胞介导免疫为主的少菌型麻风病,39.0%呈阳性结果。这些百分比值显著高于基于现有酚糖脂-I方法获得的值,表明检测MMP-II抗体将有助于麻风病的诊断。